<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">

<channel>
	<title>ANTABIO™ – Delivering Tomorrow's Antibacterials » News &amp; Events</title>
	
	<link>http://www.antabio.com</link>
	<description />
	<lastBuildDate>Thu, 16 Feb 2012 18:45:31 +0000</lastBuildDate>
	<language>fr</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.feedburner.com/Antabio-en" /><feedburner:info uri="antabio-en" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item>
		<title>Renowned leader in the anti-infective drug industry invests in ANTABIO</title>
		<link>http://feedproxy.google.com/~r/Antabio-en/~3/b_VapckeVOA/renowned-leader-in-the-anti-infective-drug-industry-invests-in-antabio</link>
		<comments>http://www.antabio.com/en/renowned-leader-in-the-anti-infective-drug-industry-invests-in-antabio#comments</comments>
		<pubDate>Thu, 12 Jan 2012 09:14:18 +0000</pubDate>
		<dc:creator>antabio</dc:creator>
				<category><![CDATA[EN]]></category>
		<category><![CDATA[Keywords]]></category>
		<category><![CDATA[News & Events]]></category>
		<category><![CDATA[Press]]></category>

		<guid isPermaLink="false">http://www.antabio.com/?p=3914</guid>
		<description><![CDATA[ANTABIO welcomes M. Christophe RICARD former CEO of the Swiss pharmaceutical group OM Pharma as its new investor &#160;]]></description>
			<content:encoded><![CDATA[<p>ANTABIO welcomes M. Christophe RICARD former CEO of the Swiss pharmaceutical group OM Pharma as its new investor</p>
<p>&nbsp;</p>
<p><span id="more-3914"></span></p>
<div class="three_fourth"></p>
<p>read the press release:</p>
<p><div class="download_box"> <a href="http://www.antabio.com/wp-content/uploads/2012/01/ANTABIO_Press_Release_12Jan2012_ENG.pdf">ANTABIO_Press_Release_12Jan2012_ENG</a> </div></p>
<p></div>
<img src="http://feeds.feedburner.com/~r/Antabio-en/~4/b_VapckeVOA" height="1" width="1"/>]]></content:encoded>
			<wfw:commentRss>http://www.antabio.com/en/renowned-leader-in-the-anti-infective-drug-industry-invests-in-antabio/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://www.antabio.com/en/renowned-leader-in-the-anti-infective-drug-industry-invests-in-antabio</feedburner:origLink></item>
		<item>
		<title>Fight against drug-resistant bacteria: Antabio highlighted in the News</title>
		<link>http://feedproxy.google.com/~r/Antabio-en/~3/lQ9PUR4jCtI/fight-against-e-coli-antabio-highlighted-in-the-news</link>
		<comments>http://www.antabio.com/en/fight-against-e-coli-antabio-highlighted-in-the-news#comments</comments>
		<pubDate>Mon, 05 Dec 2011 14:53:46 +0000</pubDate>
		<dc:creator>antabio</dc:creator>
				<category><![CDATA[EN]]></category>
		<category><![CDATA[Keywords]]></category>
		<category><![CDATA[News & Events]]></category>
		<category><![CDATA[Press]]></category>

		<guid isPermaLink="false">http://www.antabio.com/?p=3422</guid>
		<description><![CDATA[Antabio is being recognized as a key player in the fight against drug-resistant bacteria. Antabio appears in the last issues of 2 magazines. &#160;]]></description>
			<content:encoded><![CDATA[<p style="text-align: left;">Antabio is being recognized as a key player in the fight against drug-resistant bacteria.</p>
<p style="text-align: left;">Antabio appears in the last issues of 2 magazines.</p>
<p style="text-align: left;"><span id="more-3422"></span></p>
<p style="text-align: left;"><div class="three_fourth"></p>
<p style="text-align: left;">for more information:</p>
<p> <div class="download_box"> <a href="http://www.antabio.com/wp-content/uploads/2011/12/article-Antabio-lUsine-nouvelle.pdf">article Antabio l&#8217;Usine nouvelle</a><a href="http://www.antabio.com/wp-content/uploads/2010/08/13.08.2010.pdf"> </a></div></p>
<p>&nbsp;</p>
<div class="download_box"> <a href="http://www.antabio.com/wp-content/uploads/2010/08/13.08.2010.pdf"> </a><a href="http://www.antabio.com/wp-content/uploads/2011/12/Midinvest-article-antabio.docx">08/11/2011Midinvest article antabio</a></div>
<p></div></p>
<p>&nbsp;</p>
<img src="http://feeds.feedburner.com/~r/Antabio-en/~4/lQ9PUR4jCtI" height="1" width="1"/>]]></content:encoded>
			<wfw:commentRss>http://www.antabio.com/en/fight-against-e-coli-antabio-highlighted-in-the-news/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://www.antabio.com/en/fight-against-e-coli-antabio-highlighted-in-the-news</feedburner:origLink></item>
		<item>
		<title>Antabio will attend the French Biotech Tour in Boston</title>
		<link>http://feedproxy.google.com/~r/Antabio-en/~3/LrVDnSJEGes/antabio-will-attend-to-the-french-biotech-tour-in-boston</link>
		<comments>http://www.antabio.com/en/antabio-will-attend-to-the-french-biotech-tour-in-boston#comments</comments>
		<pubDate>Thu, 08 Sep 2011 14:58:02 +0000</pubDate>
		<dc:creator>antabio</dc:creator>
				<category><![CDATA[EN]]></category>
		<category><![CDATA[Keywords]]></category>
		<category><![CDATA[News & Events]]></category>
		<category><![CDATA[Press]]></category>

		<guid isPermaLink="false">http://www.antabio.com/?p=3270</guid>
		<description><![CDATA[Antabio will attend the French Biotech Tour in Boston from the 20 to 21 september 2011 What is the French Biotech Tour? The FRENCH BIOTECH TOURS aim to provide industry professionals with essential contacts and strategic partnership opportunities in a specific therapeutic field. Former participants include large pharmaceutical laboratories (Amgen, Abbott, Johnson &#38; Johnson, Novartis, Sanofi Pasteur, Sanofi-Aventis, Merck, [...]]]></description>
			<content:encoded><![CDATA[<p>Antabio will attend the French Biotech Tour in Boston from the 20 to 21 september 2011</p>
<p><strong>What is the French Biotech Tour?</strong></p>
<div id="sc-main">
<div><span id="more-3270"></span></div>
</div>
<p>The <strong>FRENCH BIOTECH TOURS</strong> aim to provide industry professionals with essential contacts and strategic partnership opportunities in a specific therapeutic field. Former participants include<strong> large pharmaceutical laboratories</strong> (Amgen, Abbott, Johnson &amp; Johnson, Novartis, Sanofi Pasteur, Sanofi-Aventis, Merck, etc.), <strong>120 American biotech companies</strong> and <strong>50 French companies</strong>.</p>
<p><a href="http://frenchbiotechtour.ubifrance-events.com/cms/en/request-meetings-with-french-companies">http://frenchbiotechtour.ubifrance-events.com/cms/en/request-meetings-with-french-companies</a></p>
<img src="http://feeds.feedburner.com/~r/Antabio-en/~4/LrVDnSJEGes" height="1" width="1"/>]]></content:encoded>
			<wfw:commentRss>http://www.antabio.com/en/antabio-will-attend-to-the-french-biotech-tour-in-boston/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://www.antabio.com/en/antabio-will-attend-to-the-french-biotech-tour-in-boston</feedburner:origLink></item>
		<item>
		<title>Fight against E.coli: Antabio highlighted in the News</title>
		<link>http://feedproxy.google.com/~r/Antabio-en/~3/lQybp5KCTtk/a-fight-against-e-coli-antabio-highlights-in-the-news</link>
		<comments>http://www.antabio.com/en/a-fight-against-e-coli-antabio-highlights-in-the-news#comments</comments>
		<pubDate>Mon, 11 Jul 2011 08:43:59 +0000</pubDate>
		<dc:creator>antabio</dc:creator>
				<category><![CDATA[EN]]></category>
		<category><![CDATA[Keywords]]></category>
		<category><![CDATA[News & Events]]></category>
		<category><![CDATA[Press]]></category>

		<guid isPermaLink="false">http://www.antabio.com/?p=2895</guid>
		<description><![CDATA[  Antabio is being recognized as a key player in the fight against E.coli. Antabio appears in the last issues of 3 of French bitotech magazines. for more information: http://www.gazettelabo.fr/  http://www.pharmaceutiques.com/]]></description>
			<content:encoded><![CDATA[<p> </p>
<p><span id="more-2895"></span>Antabio is being recognized as a key player in the fight against E.coli.</p>
<p>Antabio appears in the last issues of 3 of French bitotech magazines.</p>
<p>for more information:</p>
<p><strong><a href="http://www.gazettelabo.fr/">http://www.gazettelabo.fr/</a></strong><strong> </strong></p>
<p><strong><a href="http://www.pharmaceutiques.com/">http://www.pharmaceutiques.com/</a></strong></p>
<img src="http://feeds.feedburner.com/~r/Antabio-en/~4/lQybp5KCTtk" height="1" width="1"/>]]></content:encoded>
			<wfw:commentRss>http://www.antabio.com/en/a-fight-against-e-coli-antabio-highlights-in-the-news/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://www.antabio.com/en/a-fight-against-e-coli-antabio-highlights-in-the-news</feedburner:origLink></item>
		<item>
		<title>Antabio obtains financial support from Oséo</title>
		<link>http://feedproxy.google.com/~r/Antabio-en/~3/gEVGmhqu1lA/antabio-obtains-financial-support-from-oseo</link>
		<comments>http://www.antabio.com/non-classe/antabio-obtains-financial-support-from-oseo#comments</comments>
		<pubDate>Mon, 04 Jul 2011 10:14:45 +0000</pubDate>
		<dc:creator>antabio</dc:creator>
				<category><![CDATA[Actualités]]></category>
		<category><![CDATA[EN]]></category>
		<category><![CDATA[Keywords]]></category>
		<category><![CDATA[News & Events]]></category>
		<category><![CDATA[Non classé]]></category>
		<category><![CDATA[Press]]></category>
		<category><![CDATA[Revue de Presse]]></category>

		<guid isPermaLink="false">http://www.antabio.com/?p=2872</guid>
		<description><![CDATA[Antabio receives a grant from Oséo to finance the proof of concept of its novel therapeutic program targeting antibiotic resistance E.coli. A press statement of this subject will be released soon.]]></description>
			<content:encoded><![CDATA[<p><span id="more-2872"></span>Antabio receives a grant from Oséo to finance the proof of concept of its novel therapeutic program targeting antibiotic resistance E.coli.</p>
<p>A press statement of this subject will be released soon.</p>
<img src="http://feeds.feedburner.com/~r/Antabio-en/~4/gEVGmhqu1lA" height="1" width="1"/>]]></content:encoded>
			<wfw:commentRss>http://www.antabio.com/non-classe/antabio-obtains-financial-support-from-oseo/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://www.antabio.com/non-classe/antabio-obtains-financial-support-from-oseo</feedburner:origLink></item>
		<item>
		<title>ANTABIO is attending the 12th National Meeting on Infectiology in Toulouse</title>
		<link>http://feedproxy.google.com/~r/Antabio-en/~3/yKwi7ixUUkc/antabio-participates-in-12th-national-days-of-infectious-diseases-jni</link>
		<comments>http://www.antabio.com/non-classe/antabio-participates-in-12th-national-days-of-infectious-diseases-jni#comments</comments>
		<pubDate>Thu, 09 Jun 2011 08:01:17 +0000</pubDate>
		<dc:creator>antabio</dc:creator>
				<category><![CDATA[EN]]></category>
		<category><![CDATA[Keywords]]></category>
		<category><![CDATA[News & Events]]></category>
		<category><![CDATA[Non classé]]></category>
		<category><![CDATA[Press]]></category>

		<guid isPermaLink="false">http://www.antabio.com/?p=2763</guid>
		<description><![CDATA[The JNI is a place for sharing experiences, exchange, updating our knowledge and practices, but also reflection on our current and future performance.]]></description>
			<content:encoded><![CDATA[<p>The JNI is a place for sharing experiences, exchange, updating our knowledge and practices, but also reflection on our current and future performance.</p>
<div class="three_fourth last"><img title="Lire la suite…" src="http://www.antabio.com/wp-includes/js/tinymce/plugins/wordpress/img/trans.gif" alt="" /><img title="Lire la suite…" src="http://www.antabio.com/wp-includes/js/tinymce/plugins/wordpress/img/trans.gif" alt="" /><span id="more-2763"></span></p>
<p><img title="Lire la suite…" src="http://www.antabio.com/wp-includes/js/tinymce/plugins/wordpress/img/trans.gif" alt="" /><div class="download_box"> <a href="http://www.antabio.com/wp-content/uploads/2011/06/12es_jni_programme.pdf">Click here to see the program</a>.</p>
<p></div><img title="Lire la suite…" src="http://www.antabio.com/wp-includes/js/tinymce/plugins/wordpress/img/trans.gif" alt="" /></div><br class="clear"/>
<img src="http://feeds.feedburner.com/~r/Antabio-en/~4/yKwi7ixUUkc" height="1" width="1"/>]]></content:encoded>
			<wfw:commentRss>http://www.antabio.com/non-classe/antabio-participates-in-12th-national-days-of-infectious-diseases-jni/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://www.antabio.com/non-classe/antabio-participates-in-12th-national-days-of-infectious-diseases-jni</feedburner:origLink></item>
		<item>
		<title>L’épidémie mortelle causée par la bactérie Escherichia coli O104:H4 nécessite une réponse rapide et concertée</title>
		<link>http://feedproxy.google.com/~r/Antabio-en/~3/fhJ7A4dlrTs/l%e2%80%99epidemie-mortelle-causee-par-la-bacterie-escherichia-coli-o104h4-necessite-une-reponse-rapide-et-concertee</link>
		<comments>http://www.antabio.com/en/l%e2%80%99epidemie-mortelle-causee-par-la-bacterie-escherichia-coli-o104h4-necessite-une-reponse-rapide-et-concertee#comments</comments>
		<pubDate>Fri, 03 Jun 2011 17:11:55 +0000</pubDate>
		<dc:creator>antabio</dc:creator>
				<category><![CDATA[Actualités]]></category>
		<category><![CDATA[Actualités & Évènements]]></category>
		<category><![CDATA[EN]]></category>
		<category><![CDATA[FR]]></category>
		<category><![CDATA[News & Events]]></category>
		<category><![CDATA[Press]]></category>
		<category><![CDATA[Revue de Presse]]></category>

		<guid isPermaLink="false">http://www.antabio.com/?p=2737</guid>
		<description />
			<content:encoded><![CDATA[<div class="three_fourth last"><img title="Lire la suite…" src="http://www.antabio.com/wp-includes/js/tinymce/plugins/wordpress/img/trans.gif" alt="" /></p>
<p><span id="more-2737"></span></p>
<p><div class="download_box"> <a href="http://www.antabio.com/wp-content/uploads/2011/06/Communiqué-de-presse-ANTABIO3.pdf">Clicker ici pour télécharger le communiqué de presse</a>.</div></p>
<p><img title="Lire la suite…" src="http://www.antabio.com/wp-includes/js/tinymce/plugins/wordpress/img/trans.gif" alt="" /></div><br class="clear"/>
<img src="http://feeds.feedburner.com/~r/Antabio-en/~4/fhJ7A4dlrTs" height="1" width="1"/>]]></content:encoded>
			<wfw:commentRss>http://www.antabio.com/en/l%e2%80%99epidemie-mortelle-causee-par-la-bacterie-escherichia-coli-o104h4-necessite-une-reponse-rapide-et-concertee/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://www.antabio.com/en/l%e2%80%99epidemie-mortelle-causee-par-la-bacterie-escherichia-coli-o104h4-necessite-une-reponse-rapide-et-concertee</feedburner:origLink></item>
		<item>
		<title>WHO day 2011 on Antibiotic resistance: Read the Statement by WHO Director-General, Dr Margaret Chan</title>
		<link>http://feedproxy.google.com/~r/Antabio-en/~3/sXSzo0Tgat0/who-day-2011-on-antibiotic-resistance-read-the-statement-by-who-director-general-dr-margaret-chan-2</link>
		<comments>http://www.antabio.com/en/who-day-2011-on-antibiotic-resistance-read-the-statement-by-who-director-general-dr-margaret-chan-2#comments</comments>
		<pubDate>Thu, 07 Apr 2011 16:46:24 +0000</pubDate>
		<dc:creator>antabio</dc:creator>
				<category><![CDATA[EN]]></category>
		<category><![CDATA[Keywords]]></category>
		<category><![CDATA[News & Events]]></category>
		<category><![CDATA[Press]]></category>

		<guid isPermaLink="false">http://www.antabio.com/?p=2709</guid>
		<description><![CDATA[When the first antibiotics were introduced in the 1940s, they were hailed as “wonder drugs”, the miracles of modern medicine. And rightly so. Widespread infections that killed many millions of people every year could now be cured.  ]]></description>
			<content:encoded><![CDATA[<div><span style="font-family: DINNextLTPro-Light; font-size: small;"><span style="font-family: DINNextLTPro-Light; font-size: small;">When the first antibiotics were introduced in the 1940s, they were hailed as “wonder drugs”, the miracles of modern medicine. And rightly so. Widespread infections that killed many millions of people every year could now be cured.</span></span></div>
<p><span style="font-family: DINNextLTPro-Light; font-size: small;"><span style="font-family: DINNextLTPro-Light; font-size: small;"> </p>
<p></span></span></p>
<div class="three_fourth last"></p>
<p><span id="more-2709"></span></p>
<p><div class="download_box"> <a href="http://www.antabio.com/wp-content/uploads/2011/04/WHD2011-DGstate-EN.pdf">Click here to download the press release.</a></div></p>
<p><img title="Lire la suite…" src="http://www.antabio.com/wp-includes/js/tinymce/plugins/wordpress/img/trans.gif" alt="" /></div><br class="clear"/>
<img src="http://feeds.feedburner.com/~r/Antabio-en/~4/sXSzo0Tgat0" height="1" width="1"/>]]></content:encoded>
			<wfw:commentRss>http://www.antabio.com/en/who-day-2011-on-antibiotic-resistance-read-the-statement-by-who-director-general-dr-margaret-chan-2/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://www.antabio.com/en/who-day-2011-on-antibiotic-resistance-read-the-statement-by-who-director-general-dr-margaret-chan-2</feedburner:origLink></item>
		<item>
		<title>An Equity Security Priming Loan granted to ANTABIO by OSEO</title>
		<link>http://feedproxy.google.com/~r/Antabio-en/~3/_t0kgH9BZM8/an-equity-security-priming-loan-granted-to-antabio-by-oseo</link>
		<comments>http://www.antabio.com/en/an-equity-security-priming-loan-granted-to-antabio-by-oseo#comments</comments>
		<pubDate>Fri, 04 Mar 2011 17:39:26 +0000</pubDate>
		<dc:creator>antabio</dc:creator>
				<category><![CDATA[EN]]></category>
		<category><![CDATA[Keywords]]></category>
		<category><![CDATA[News & Events]]></category>
		<category><![CDATA[Press]]></category>

		<guid isPermaLink="false">http://www.antabio.com/?p=2535</guid>
		<description><![CDATA[  ANTABIO announces that an Equity Security Priming Loan (&#8220;Prêt participatif à l&#8217;amorçage&#8221;) has been granted to Antabio by Oseo, the French Public Establisment responsible for supporting innovation and growth of SMEs in France.]]></description>
			<content:encoded><![CDATA[<p> <em><span style="font-size: small;"> </span></em>ANTABIO announces that an Equity Security Priming Loan (&#8220;Prêt participatif à l&#8217;amorçage&#8221;) has been granted to Antabio by Oseo, the French Public Establisment responsible for supporting innovation and growth of SMEs in France.</p>
<div class="three_fourth last"><span id="more-2535"></span><img title="Lire la suite…" src="http://www.antabio.com/wp-includes/js/tinymce/plugins/wordpress/img/trans.gif" alt="" /><img title="Lire la suite…" src="http://www.antabio.com/wp-includes/js/tinymce/plugins/wordpress/img/trans.gif" alt="" /><div class="download_box"> <a href="http://www.antabio.com/wp-content/uploads/2011/03/communiqué-de-presse-Oséo-ENGLISH-VERSION.pdf">Click here to download the press release</a>.</div></p>
<p><img title="Lire la suite…" src="http://www.antabio.com/wp-includes/js/tinymce/plugins/wordpress/img/trans.gif" alt="" /></div><br class="clear"/>
<img src="http://feeds.feedburner.com/~r/Antabio-en/~4/_t0kgH9BZM8" height="1" width="1"/>]]></content:encoded>
			<wfw:commentRss>http://www.antabio.com/en/an-equity-security-priming-loan-granted-to-antabio-by-oseo/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://www.antabio.com/en/an-equity-security-priming-loan-granted-to-antabio-by-oseo</feedburner:origLink></item>
		<item>
		<title>ANTABIO announces the completion of the first round of its 1 million euro seed financing</title>
		<link>http://feedproxy.google.com/~r/Antabio-en/~3/k5aFLY75-2g/antabio-announces-the-completion-of-the-first-round-of-its-1-million-euro-seed-financing</link>
		<comments>http://www.antabio.com/non-classe/antabio-announces-the-completion-of-the-first-round-of-its-1-million-euro-seed-financing#comments</comments>
		<pubDate>Mon, 14 Feb 2011 11:43:20 +0000</pubDate>
		<dc:creator>antabio</dc:creator>
				<category><![CDATA[EN]]></category>
		<category><![CDATA[Keywords]]></category>
		<category><![CDATA[News & Events]]></category>
		<category><![CDATA[Non classé]]></category>
		<category><![CDATA[Press]]></category>

		<guid isPermaLink="false">http://www.antabio.com/?p=2482</guid>
		<description><![CDATA[The raising of 309K€ was conducted in partnership with WISEED, a crowd funding internet platform. &#8221; This transaction, which involved the constitution of a holding of shareholders in less than two months, is one of the most successful deals carried out by Wiseed date&#8221; says enthusiastically Thierry Merquio, CEO of Wiseed.  ]]></description>
			<content:encoded><![CDATA[<p>The raising of 309K€ was conducted in partnership with WISEED, a crowd funding internet platform. &#8221; This transaction, which involved the constitution of a holding of shareholders in less than two months, is one of the most successful deals carried out by Wiseed date&#8221; says enthusiastically Thierry Merquio, CEO of Wiseed.</p>
<p> <div class="three_fourth last"></p>
<p><img title="Lire la suite…" src="http://www.antabio.com/wp-includes/js/tinymce/plugins/wordpress/img/trans.gif" alt="" /><span id="more-2482"></span></p>
<div class="download_box"> <a href="http://www.antabio.com/wp-content/uploads/2011/02/Press_Release_Antabio-Wiseed_Eng.pdf">Click here to download the press release</a>.</div>
<div class="download_box"> <a href="http://www.antabio.com/wp-content/uploads/2011/02/Art-ANTABIO-UK.pdf">Click here to download the article of Biotech &amp; Finances</a>.</div>
<p></div><br class="clear"/></p>
<img src="http://feeds.feedburner.com/~r/Antabio-en/~4/k5aFLY75-2g" height="1" width="1"/>]]></content:encoded>
			<wfw:commentRss>http://www.antabio.com/non-classe/antabio-announces-the-completion-of-the-first-round-of-its-1-million-euro-seed-financing/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://www.antabio.com/non-classe/antabio-announces-the-completion-of-the-first-round-of-its-1-million-euro-seed-financing</feedburner:origLink></item>
	</channel>
</rss>

